Monodisperse Nanoliter Dispensing of Reagents

Monodisperse Nanoliter Dispensing of Reagents Enabling Medical Diagnostic Biosensor Manufacturing

The significant advancements happening now in medical diagnostic biosensor development are especially noticeable to electrochemical sensors. These sensors require precision reagent dispensing with pump technologies that can provide exceptional volume and placement accuracy.

Traditionally, reagent dispensing in biosensor production was performed manually or with automatic pipettes. This often resulted in droplets of varying sizes, leading to inconsistencies and uncertainties in biosensor results. By contrast, precision dispensing is crucial for ensuring more reliable sensor performance. In the past, reagent dispensing in biosensor production relied on microliter volumes, which often led to material wastage, increased production costs, and limitations in device miniaturization. Nanoliter dispensing, in contrast, involves the precise delivery of reagents in lower uncertainty. This precision minimizes reagent consumption, reduces production costs, and facilitates the creation of smaller, more portable biosensors.

Reagents are the significant cost component of a biosensor. Precision formation and deposition of droplets for both contact and non-contact applications enables consistent expense management of costly reagents. Pump technologies that aspirate exact amounts further mitigate cost risks, particularly in R&D environments where droplet deposition occurs intermittently rather than at full production volume.

It is also helpful that a nanoliter dispensing solution scale from lab to production so that process controls developed in R&D transfer with minimal changes to full rate production lines.

Introducing Kaiku: New Data Insights in Manufacturing

Ginolis is proud to announce the launch of Kaiku, a groundbreaking software designed to provide unparalleled insights into manufacturing processes. Kaiku represents a significant leap forward in data analytics and process optimization.

A Journey of Innovation and Transformation

A Journey of Innovation and Transformation

Ginolis has undergone a significant internal transformation, prompting a strategic reassessment of our brand identity to align with our current operation and customer segments. This evolution has strengthened our position in the market and enabled us to meet our customers’ evolving needs.   

Introducing CEO Ginolis

Appointment news

Kauko Väinämö has been appointed as CEO of Ginolis Oy from September 1, 2022. Kauko has more than 30 years of solid knowledge in strategic leadership, having managed factories and R&D organizations in various technology sectors.

Ginolis Webinar

Are you ready to understand what assay production is?

Send us your application!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We can answer all your questions!